These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28627758)

  • 1. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.
    Nigjeh EN; Chen R; Allen-Tamura Y; Brand RE; Brentnall TA; Pan S
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
    Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
    J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraoral mechanical stress application on the expression of a force-responsive prognostic marker associated with system disease progression.
    Zhang Y; Kou X; Jiang N; Liu Y; Tay FR; Zhou Y
    J Dent; 2017 Feb; 57():57-65. PubMed ID: 27979689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma.
    Waragai Y; Suzuki R; Takagi T; Sugimoto M; Asama H; Watanabe K; Kikuchi H; Hikichi T; Masamune A; Kang Y; Fleming JB; Ohira H
    Pancreatology; 2016; 16(6):1044-1050. PubMed ID: 27665173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum retinol binding protein 4 and galectin-3 binding protein as novel markers for postmenopausal nonalcoholic fatty liver disease.
    Cai H; Lu S; Chen Y; Das Mbbs Mrcog S; Niu Z; Zhuo G; Lai L; Zhang Z
    Clin Biochem; 2018 Jun; 56():95-101. PubMed ID: 29679552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated plasma proteomics and N-glycoproteomics reveals alterations in the N-glycosylation in Chinese hepatocellular carcinoma patients.
    Zeng J; Rong W; Meng B; Zheng L; Peng T; Zhai R; Jiang Y; Xiao T; Fang X; Zhang Y; Zhao Y; Dai X
    Proteomics Clin Appl; 2024 Jul; 18(4):e202300029. PubMed ID: 38345243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
    Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
    J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
    Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
    Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis.
    Nigjeh EN; Chen R; Brand RE; Petersen GM; Chari ST; von Haller PD; Eng JK; Feng Z; Yan Q; Brentnall TA; Pan S
    J Proteome Res; 2017 Feb; 16(2):665-676. PubMed ID: 27995795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis.
    Krishnan S; Whitwell HJ; Cuenco J; Gentry-Maharaj A; Menon U; Pereira SP; Gaspari M; Timms JF
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reusing Peptide Spectral Reference Libraries to Discover Putative Plasma Biomarkers of Response to Cancer Chemotherapy.
    O'Rourke MB; Hansbro PP; Molloy MP
    Methods Mol Biol; 2024; 2823():241-251. PubMed ID: 39052224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoproteins and glycoproteomics in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
    O'Rourke MB; Sahni S; Samra J; Mittal A; Molloy MP
    J Proteomics; 2021 Jan; 231():103998. PubMed ID: 33027703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in serologic detection of human pancreatic adenocarcinoma.
    Eskelinen M; Haglund U
    Scand J Gastroenterol; 1999 Sep; 34(9):833-44. PubMed ID: 10522599
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.
    Grassadonia A; Tinari N; Natoli C; Yahalom G; Iacobelli S
    Dis Markers; 2013; 35(6):747-52. PubMed ID: 24347795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.